Role of osteopontin in cellular signaling and toxicant injury.
暂无分享,去创建一个
[1] R. Hynes,et al. Transformed mammalian cells secrete specific proteins and phosphoproteins , 1979, Cell.
[2] H. Dvorak,et al. A secreted phosphoprotein marker for neoplastic transformation of both epithelial and fibroblastic cells , 1983, Nature.
[3] D. Denhardt,et al. Molecular cloning of a tumor promoter‐inducible mRNA found in JB6 mouse epidermal cells: Induction is stable at high, but not at low, cell densities , 1987, Journal of cellular biochemistry.
[4] D. Tenen,et al. Secreted phosphoproteins associated with neoplastic transformation: close homology with plasma proteins cleaved during blood coagulation. , 1988, Cancer research.
[5] F. Blattner,et al. Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene. Definition of a novel T cell-dependent response associated with genetic resistance to bacterial infection , 1989, The Journal of experimental medicine.
[6] H. Cantor,et al. Definition of a specific interaction between the early T lymphocyte activation 1 (Eta-1) protein and murine macrophages in vitro and its effect upon macrophages in vivo , 1990, The Journal of experimental medicine.
[7] H. Cantor,et al. Polyclonal B cell activation by the Eta-1 cytokine and the development of systemic autoimmune disease. , 1991, Journal of immunology.
[8] S. Colucci,et al. Recognition of osteopontin and related peptides by an alpha v beta 3 integrin stimulates immediate cell signals in osteoclasts. , 1991, The Journal of biological chemistry.
[9] S. Schwartz,et al. Molecular cloning and characterization of 2B7, a rat mRNA which distinguishes smooth muscle cell phenotypes in vitro and is identical to osteopontin (secreted phosphoprotein I, 2aR). , 1991, Biochemical and biophysical research communications.
[10] M. C. Farach-Carson,et al. Evidence for the formation of a complex between osteopontin and osteocalcin , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[11] E. Manseau,et al. Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces. , 1992, Molecular biology of the cell.
[12] A. Zallone,et al. Immediate cell signal by bone-related peptides in human osteoclast-like cells. , 1993, The American journal of physiology.
[13] A. Chambers,et al. Inhibition of Arg-Gly-Asp (RGD)-mediated cell adhesion to osteopontin by a monoclonal antibody against osteopontin. , 1994, The Journal of biological chemistry.
[14] M. Inobe,et al. In vivo cytokine gene expression in various T cell subsets of the autoimmune MRL/Mp-lpr/lpr mouse. , 1994, Autoimmunity.
[15] S M Schwartz,et al. Macrophages express osteopontin during repair of myocardial necrosis. , 1994, The American journal of pathology.
[16] D. Cheresh,et al. Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.
[17] T. Yue,et al. Osteopontin-stimulated vascular smooth muscle cell migration is mediated by beta 3 integrin. , 1994, Experimental cell research.
[18] D. Laskin,et al. Osteopontin inhibits induction of nitric oxide synthase gene expression by inflammatory mediators in mouse kidney epithelial cells. , 1994, The Journal of biological chemistry.
[19] E. Manseau,et al. Osteopontin expression and distribution in human carcinomas. , 1994, The American journal of pathology.
[20] L. Schook,et al. Xenobiotics and inflammation , 1994 .
[21] B. Berse,et al. Specific reduction in osteopontin synthesis by antisense RNA inhibits the tumorigenicity of transformed Rat1 fibroblasts. , 1994, Oncogene.
[22] S. Schwartz,et al. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. , 1994, Circulation research.
[23] B. Aggarwal,et al. The p60 Tumor Necrosis Factor (TNF) Receptor-associated Kinase (TRAK) Binds Residues 344–397 within the Cytoplasmic Domain Involved in TNF Signaling (*) , 1995, The Journal of Biological Chemistry.
[24] S. Schwartz,et al. Molecular and cellular biology of osteopontin Potential role in cardiovascular disease. , 1995, Trends in cardiovascular medicine.
[25] T. Ishida,et al. Expression of wild-type and mutated rabbit osteopontin in Escherichia coli, and their effects on adhesion and migration of P388D1 cells. , 1995, The Biochemical journal.
[26] V. Castronovo,et al. Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer. , 1995, The American journal of pathology.
[27] S. Hirota,et al. Expression of bone matrix protein messenger ribonucleic acids in human breast cancers. Possible involvement of osteopontin in development of calcifying foci. , 1995, Laboratory investigation; a journal of technical methods and pathology.
[28] L. Su,et al. Expression of antisense osteopontin RNA inhibits tumor promoter-induced neoplastic transformation of mouse JB6 epidermal cells. , 1995, Oncogene.
[29] Shiaw-Min Hwang,et al. Osteopontin‐Induced Modifications of Cellular Functions a , 1995, Annals of the New York Academy of Sciences.
[30] S. Schwartz,et al. Osteopontin and beta 3 integrin are coordinately expressed in regenerating endothelium in vivo and stimulate Arg-Gly-Asp-dependent endothelial migration in vitro. , 1995, Circulation research.
[31] J. Balligand,et al. Glucocorticoids Increase Osteopontin Expression in Cardiac Myocytes and Microvascular Endothelial Cells , 1995, The Journal of Biological Chemistry.
[32] R. Ross,et al. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. , 1995, The Journal of clinical investigation.
[33] M. McKee,et al. Secretion of osteopontin by macrophages and its accumulation at tissue surfaces during wound healing in mineralized tissues: A potential requirement for macrophage adhesion and phagocytosis , 1996, The Anatomical record.
[34] D. Cheresh,et al. Osteopontin activation of c-src in human melanoma cells requires the cytoplasmic domain of the integrin alpha v-subunit. , 1996, Endocrinology.
[35] A. Oates,et al. The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model. , 1996, Oncogene.
[36] B. Padanilam,et al. Insulin-like growth factor I-enhanced renal expression of osteopontin after acute ischemic injury in rats. , 1996, Endocrinology.
[37] M. McKee,et al. Osteopontin at mineralized tissue interfaces in bone, teeth, and osseointegrated implants: Ultrastructural distribution and implications for mineralized tissue formation, turnover, and repair , 1996, Microscopy research and technique.
[38] D. Laskin,et al. Osteopontin inhibits nitric oxide production and cytotoxicity by activated RAW264.7 macrophages , 1996, Journal of leukocyte biology.
[39] D. Sheppard,et al. Osteopontin N-terminal Domain Contains a Cryptic Adhesive Sequence Recognized by α9β1 Integrin* , 1996, The Journal of Biological Chemistry.
[40] Toshitaka Nakamura,et al. Changes in biological activity of bone cells in ovariectomized rats revealed by in situ hybridization , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[41] M. Detmar,et al. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin. , 1996, The American journal of pathology.
[42] J. Paulauskis,et al. Differential screening identifies genetic markers of monocyte to macrophage maturation , 1996, Journal of leukocyte biology.
[43] M. Glimcher,et al. Receptor-Ligand Interaction Between CD44 and Osteopontin (Eta-1) , 1996, Science.
[44] K. Hruska,et al. Osteopontin stimulates gelsolin-associated phosphoinositide levels and phosphatidylinositol triphosphate-hydroxyl kinase. , 1996, Molecular biology of the cell.
[45] S. Rittling,et al. Osteopontin expression in mammary gland development and tumorigenesis. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[46] J. Robb,et al. Electrophysiological Responses of Human Bone Cells to Mechanical Stimulation: Evidence for Specific Integrin Function in Mechanotransduction , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[47] R. Johnson,et al. Osteopontin in chronic puromycin aminonucleoside nephrosis. , 1997, Journal of the American Society of Nephrology : JASN.
[48] K. Ramos,et al. Differential processing of osteopontin characterizes the proliferative vascular smooth muscle cell phenotype induced by allylamine , 1997, Journal of cellular biochemistry.
[49] S. Teitelbaum,et al. Osteoclasts, macrophages, and the molecular mechanisms of bone resorption , 1997, Journal of leukocyte biology.
[50] T. Martin,et al. Calcitonin receptors, bone sialoprotein and osteopontin are expressed in primary breast cancers , 1997, International journal of cancer.
[51] F. O'Malley,et al. Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[52] J. Klein-Nulend,et al. Mechanical stimulation of osteopontin mRNA expression and synthesis in bone cell cultures , 1997, Journal of cellular physiology.
[53] A. Oates,et al. Isolation of and effector for metastasis-inducing DNAs from a human metastatic carcinoma cell line , 1997, Oncogene.
[54] M. Tsao,et al. ras mutation and expression of the ras‐regulated genes osteopontin and cathepsin L in human esophageal cancer , 1997, International journal of cancer.
[55] Hiroshi Sato,et al. Requirement for Vα14 NKT Cells in IL-12-Mediated Rejection of Tumors , 1997 .
[56] M. Murakami,et al. Osteopontin, a Coordinator of Host Defense System: a Cytokine or an Extracellular Adhesive Protein? , 1997, Microbiology and immunology.
[57] H. Wu,et al. Upregulation of osteopontin in ischemia-induced renal failure in rats: a role for ET-1? , 1997, Biochemical and biophysical research communications.
[58] R. Young,et al. A chemoattractant cytokine associated with granulomas in tuberculosis and silicosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[59] S. Schwartz,et al. Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening after endothelial denudation. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[60] S. Manolagas,et al. Osteopontin expression by osteoclast and osteoblast progenitors in the murine bone marrow: demonstration of its requirement for osteoclastogenesis and its increase after ovariectomy. , 1997, Endocrinology.
[61] V. Sondak,et al. Type 1 versus type 2 cytokine release by Vbeta T cell subpopulations determines in vivo antitumor reactivity: IL-10 mediates a suppressive role. , 1997, Journal of immunology.
[62] G. Rodan. Control of bone formation and resorption: biological and clinical perspective. , 1998, Journal of cellular biochemistry. Supplement.
[63] C. McCulloch,et al. Analysis of intracellular osteopontin as a marker of osteoblastic cell differentiation and mesenchymal cell migration. , 1998, European journal of oral sciences.
[64] J. M. Scholtz,et al. Osteopontin is a ligand for the alpha4beta1 integrin. , 1998, Journal of cell science.
[65] R. Kreisberg,et al. Regulation of proximal tubular osteopontin in experimental hydronephrosis in the rat. , 1998, Kidney international.
[66] R. Jilka,et al. Cytokines, bone remodeling, and estrogen deficiency: a 1998 update. , 1998, Bone.
[67] K. Hruska,et al. c-Src Is Required for Stimulation of Gelsolin-associated Phosphatidylinositol 3-Kinase* , 1998, The Journal of Biological Chemistry.
[68] J. F. Harris,et al. Osteopontin expression in a group of lymph node negative breast cancer patients , 1998, International journal of cancer.
[69] N. Fausto,et al. NF-κB Mediates αvβ3 Integrin-induced Endothelial Cell Survival , 1998, The Journal of cell biology.
[70] H. Blair. How the osteoclast degrades bone , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.
[71] C. Murry,et al. Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. , 1998, The American journal of pathology.
[72] T. Martin,et al. Casein kinase 2 phosphorylation of recombinant rat osteopontin enhances adhesion of osteoclasts but not osteoblasts , 1998, Journal of cellular physiology.
[73] D. Lt,et al. Integrin-mediated Signaling in the Regulation of Osteoclast Adhesion and Activation , 1998 .
[74] B. Hogan,et al. Altered wound healing in mice lacking a functional osteopontin gene (spp1). , 1998, The Journal of clinical investigation.
[75] M. McKee,et al. Mice Lacking Osteopontin Show Normal Development and Bone Structure but Display Altered Osteoclast Formation In Vitro , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[76] R. Wüthrich,et al. Enhanced osteopontin expression and macrophage infiltration in MRL-Fas(lpr) mice with lupus nephritis. , 1998, Autoimmunity.
[77] T. Yue,et al. Delayed Expression of Osteopontin after Focal Stroke in the Rat , 1998, The Journal of Neuroscience.
[78] A. Chambers,et al. Osteopontin inhibits inducible nitric oxide synthase activity in rat vascular tissue. , 1998, The American journal of physiology.
[79] H. Yokozaki,et al. Co‐expression of osteopontin and CD44v9 in gastric cancer , 1998, International journal of cancer.
[80] M. Noda,et al. Osteopontin expression and function: Role in bone remodeling , 1998, Journal of cellular biochemistry. Supplement.
[81] L. Matrisian,et al. Distinct roles of osteopontin in host defense activity and tumor survival during squamous cell carcinoma progression in vivo. , 1998, Cancer research.
[82] R. Atkins,et al. A functional role for osteopontin in experimental crescentic glomerulonephritis in the rat. , 1998, Proceedings of the Association of American Physicians.
[83] C. Gilles,et al. The LCC15-MB human breast cancer cell line expresses osteopontin and exhibits an invasive and metastatic phenotype. , 1998, Experimental cell research.
[84] D. Cheresh,et al. The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development. , 1999, The Journal of clinical investigation.
[85] G D Roodman,et al. Cell biology of the osteoclast. , 1999, Experimental hematology.
[86] Y. Kitamura,et al. Role of Osteopontin in Bone Remodeling Caused by Mechanical Stress , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[87] L. Gerstenfeld. Osteopontin in Skeletal Tissue Homeostasis: An Emerging Picture of the Autocrine/Paracrine Functions of the Extracellular Matrix , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[88] M. Colombo,et al. Interleukin-12 as an adjuvant for cancer immunotherapy. , 1999, Methods.
[89] C. Alpers,et al. Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. , 1999, Kidney international.
[90] J. Klein-Nulend,et al. MECHANOTRANSDUCTION IN BONE : ROLE OF THE LACUNOCANALICULAR NETWORK , 1999 .
[91] E. Thompson,et al. Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer. , 1999, Laboratory investigation; a journal of technical methods and pathology.
[92] R. Young,et al. Attenuated Host Resistance againstMycobacterium bovis BCG Infection in Mice Lacking Osteopontin , 1999, Infection and Immunity.
[93] H. Maguire,et al. Tumor-induced interleukin-10 inhibits type 1 immune responses directed at a tumor antigen as well as a non-tumor antigen present at the tumor site. , 1999, Cancer research.
[94] J. Sleeman,et al. CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis. , 1999, Cancer research.
[95] S. Abe,et al. Vascular endothelial growth factor and osteopontin in stage I lung adenocarcinoma. , 1999, American journal of respiratory and critical care medicine.
[96] G. Chupp,et al. Osteopontin is associated with T cells in sarcoid granulomas and has T cell adhesive and cytokine-like properties in vitro. , 1999, Journal of immunology.
[97] K. Yokote,et al. Enhanced expression of osteopontin by high glucose in cultured rat aortic smooth muscle cells. , 1999, Biochemical and Biophysical Research Communications - BBRC.
[98] J. Cha,et al. Transient upregulation of osteopontin mRNA in hippocampus and striatum following global forebrain ischemia in rats , 1999, Neuroscience Letters.
[99] M. C. Ling,et al. Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells , 1999, Oncogene.
[100] M D McKee,et al. Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin. , 1999, Circulation research.
[101] H. Ikeda,et al. Expression of osteopontin in Kupffer cells and hepatic macrophages and Stellate cells in rat liver after carbon tetrachloride intoxication: a possible factor for macrophage migration into hepatic necrotic areas. , 1999, Biochemical and biophysical research communications.
[102] M Noda,et al. Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[103] A. Chambers,et al. Reduced tolerance to acute renal ischemia in mice with a targeted disruption of the osteopontin gene. , 1999, Kidney international.
[104] A. Aruffo,et al. CD44 is not an adhesive receptor for osteopontin , 1999, Journal of cellular biochemistry.
[105] D. Sheppard,et al. The Integrin α9β1 Binds to a Novel Recognition Sequence (SVVYGLR) in the Thrombin-cleaved Amino-terminal Fragment of Osteopontin* , 1999, The Journal of Biological Chemistry.
[106] P. Mäenpää,et al. Cross-linking of Osteopontin by Tissue Transglutaminase Increases Its Collagen Binding Properties* , 1999, The Journal of Biological Chemistry.
[107] R. Atkins,et al. IL-1 up-regulates osteopontin expression in experimental crescentic glomerulonephritis in the rat. , 1999, The American journal of pathology.
[108] D. Denhardt,et al. Osteopontin Function in Pathology: Lessons from Osteopontin-Deficient Mice , 1999, Nephron Experimental Nephrology.
[109] M. D. de Broe,et al. Differences in osteopontin up-regulation between proximal and distal tubules after renal ischemia/reperfusion. , 1999, Kidney international.
[110] M. Nangaku,et al. Complement membrane attack complex (C5b-9) mediates interstitial disease in experimental nephrotic syndrome. , 1999, Journal of the American Society of Nephrology : JASN.
[111] A. Chambers,et al. The Role of Osteopontin in the Development of Granulomatous Lesions in Lung , 2000, Microbiology and immunology.
[112] R. Kalluri,et al. Osteopontin expressed by renal tubular epithelium mediates interstitial monocyte infiltration in rats. , 2000, American journal of physiology. Renal physiology.
[113] Matthew J. Silva,et al. Gelsolin Deficiency Blocks Podosome Assembly and Produces Increased Bone Mass and Strength , 2000, The Journal of cell biology.
[114] E. Clark,et al. Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells* , 2000, The Journal of Biological Chemistry.
[115] K. Hruska,et al. Rho-A Is Critical for Osteoclast Podosome Organization, Motility, and Bone Resorption* , 2000, The Journal of Biological Chemistry.
[116] M. Le Hir,et al. Lack of in vivo function of osteopontin in experimental anti-GBM nephritis. , 2000, Journal of the American Society of Nephrology : JASN.
[117] M. Sy,et al. Regulation of no synthesis induced by inflammatory mediators in RAW264.7 cells: collagen prevents inhibition by osteopontin. , 2000, Cytokine.
[118] M. Glimcher,et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. , 2000, Science.
[119] W. DeGrado,et al. The Activation State of αvβ3Regulates Platelet and Lymphocyte Adhesion to Intact and Thrombin-cleaved Osteopontin* , 2000, The Journal of Biological Chemistry.
[120] K. Chihara,et al. Parathyroid Hormone-activated Volume-sensitive Calcium Influx Pathways in Mechanically Loaded Osteocytes* , 2000, The Journal of Biological Chemistry.
[121] T. Nam,et al. Thrombospondin and osteopontin bind to insulin-like growth factor (IGF)-binding protein-5 leading to an alteration in IGF-I-stimulated cell growth. , 2000, Endocrinology.
[122] M. Young,et al. Factor H Binding to Bone Sialoprotein and Osteopontin Enables Tumor Cell Evasion of Complement-mediated Attack* , 2000, The Journal of Biological Chemistry.
[123] D. Denhardt,et al. Osteopontin is required for full expression of the transformed phenotype by the ras oncogene , 2000, British Journal of Cancer.
[124] M. Glogauer,et al. Intracellular osteopontin is an integral component of the CD44‐ERM complex involved in cell migration , 2000, Journal of cellular physiology.
[125] Yi-hung Lin,et al. Coupling of Osteopontin and Its Cell Surface Receptor CD44 to the Cell Survival Response Elicited by Interleukin-3 or Granulocyte-Macrophage Colony-Stimulating Factor , 2000, Molecular and Cellular Biology.
[126] M. Noda,et al. Printed in U.S.A. Copyright © 2001 by The Endocrine Society Osteopontin Facilitates Angiogenesis, Accumulation of , 2000 .
[127] R. Marcus. Mechanisms of Exercise Effects on Bone , 2002 .